David Rolfe Edwards Lifesciences Corp Transaction History

Wedgewood Partners Inc

$522 Million
Q3 2024

A detailed history of David Rolfe (Wedgewood Partners Inc) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wedgewood Partners Inc holds 359,257 shares of EW stock, worth $25 Million. This represents 4.54% of its overall portfolio holdings.

Number of Shares

359,257

Previous 354,427 1.36%

Holding current value

$25 Million

Previous $32.7 Million 27.59%

% of portfolio

4.54%

Previous 6.52%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $288,351 - $452,957	4,830 Added 1.36%	359,257 $23.7 Million
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $9.19 Million - $10.3 Million	108,976 Added 44.4%	354,427 $32.7 Million
Q1 2024 May 16, 2024	SELL	$72.54 - $95.56 $377,280 - $497,007	-5,201 Reduced 2.07%	245,451 $23.5 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $3.51 Million - $4.42 Million	56,855 Added 29.34%	250,652 $19.1 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $13.4 Million - $18.1 Million	193,797 New	193,797 $13.4 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $1.21 Million - $1.41 Million	-14,897 Reduced 4.51%	315,173 $29.7 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $274,019 - $311,841	-3,690 Reduced 1.11%	330,070 $27.3 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $145,683 - $186,509	2,133 Added 0.64%	333,760 $24.9 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $27.3 Million - $35.6 Million	331,627 New	331,627 $27.4 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $1.52 Million - $2.25 Million	-17,531 Reduced 4.89%	340,689 $32.4 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $517,039 - $650,812	5,071 Added 1.44%	358,220 $42.2 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $12.7 Million - $15.6 Million	-119,478 Reduced 25.28%	353,149 $45.7 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $1.12 Million - $1.34 Million	-10,909 Reduced 2.26%	472,627 $53.5 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $2.54 Million - $3.18 Million	-30,352 Reduced 5.91%	483,536 $50.1 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $6.38 Million - $7.35 Million	-81,068 Reduced 13.63%	513,888 $43 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $2.64 Million - $3.35 Million	-36,762 Reduced 5.82%	594,956 $54.3 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $2.47 Million - $3.22 Million	-36,824 Reduced 5.51%	631,718 $50.4 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $24.8 Million - $33.2 Million	431,342 Added 181.85%	668,542 $46.2 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $7.17 Million - $11.1 Million	-136,862 Reduced 36.59%	237,200 $44.7 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $7.51 Million - $8.6 Million	-104,727 Reduced 21.87%	374,062 $87.3 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $2.55 Million - $3.13 Million	-41,504 Reduced 7.98%	478,789 $105 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $7.83 Million - $9.05 Million	-140,526 Reduced 21.27%	520,293 $96.1 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $7.68 Million - $10.3 Million	-160,313 Reduced 19.52%	660,819 $126 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $100,802 - $123,673	2,172 Added 0.27%	821,132 $126 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $3.31 Million - $4.2 Million	-72,450 Reduced 8.13%	818,960 $143 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $48.1 Million - $58.1 Million	-1,132,341 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $7.71 Million - $9.84 Million	-207,421 Reduced 15.48%	1,132,341 $158 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $111,000 - $129,396	-3,285 Reduced 0.24%	1,339,762 $151 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $48.7 Million - $52.2 Million	1,343,047	1,343,047 $147 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track David Rolfe's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedgewood Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedgewood Partners Inc and David Rolfe with notifications on news.

Account